Overview
Arthec is a company that develops the Pearl method, a tissue-engineered solution for osteoarthritis that aims to regenerate cartilage and restore joint function without the need for invasive joint replacement surgery. The method utilizes proprietary technology to create structured cartilage tissue that mimics the properties of native cartilage, ensuring natural integration within the joint. Arthec's approach focuses on reducing invasiveness and promoting faster recovery for patients with early to moderate cartilage lesions.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-09-04. Active
32 1050 1764 1000 0090 8629 4544- 37 1050 1764 1000 0090 8629 4551
- 27 1050 1764 1000 0025 1392 3058
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 25, 2025 | Bankruptcy notice | |
| Apr 25, 2025 | Call to heirs |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 6, 2026 | Aid for research and development projects: experimental development | $3.5M$3,479,738 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| May 6, 2026 | Aid for research and development projects: industrial research | $1.5M$1,459,446 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Feb 19, 2020 | Aid for SME access to finance — aid for start-ups | $219.1K$219,148 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-09-08 | Metoda PEARL - produkcja in vitro pełnowartościowej autologicznej chrząstki szklistej gotowej do wdrożenia, która biologicznie przywraca funkcje stawu | $4.6M$4,591,879 | Fundusze Europejskie dla Nowoczesnej Gospodarki |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to submit declarations of will concerning the rights and obligations on behalf of the company. In the case of the appointment of a multi-member management board, joint action by two members of the management board acting jointly is required to submit declarations of will concerning the rights and obligations on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Sławomir Jaros (46)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Marek Bogdan Putko (59) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-01 | Share capital change (100,000.00 PLN → 110,616.70 PLN) | |
| 2024-04-30 | Entered in the register |
FAQ
Last updated: 2026-06-22